Investors & MediaNews release
Investors VasThera’s Dr. Sang Won Kang to Present at the 2022 BIO International Convention | |
---|---|
VasThera(bd@vasthera.com)Date : 2022-06-14View : 4672 | |
VasThera’s Dr. Sang Won Kang to Present
at the 2022 BIO International Convention VasThera announced today that Dr. Sang Won Kang, CEO of VasThera, presented at the 2022 BIO International Convention June 13-16, 2022, in San
Diego, California. Dr. Sang Won Kang spoke to senior biotech executives,
business development leaders, and investors on De novo Drug design for Cardiovascular
disease, especially VTA-04 for pulmonary arterial hypertension. The
annual BIO International Convention, hosted by Biotechnology Innovation
Organization (BIO), is the world’s largest industry gathering and brings
together thousands of global biotechnology and biopharmaceutical leaders. The
four-day, in-person event includes networking, programming, and partnering
opportunities. Dr.
Kang have been studying the redox signal network over 20 years. Related to
the arterial vessels, the core science has been published the top journals,
Nature, Molecular cell and Circulation. Based on this achievement, Dr. Kang
founded VasThera in 2018. Recently, VasThera finished the series B investment,
around 20 million us dollars. According
to the global data report, the global pulmonary arterial hypertension(PAH)
market value was approximately $ 4.5B in 2019, and it will be grown by $ 7.5B
in 2029. PAH patients are suffering because the sequential combination therapy
depending on disease progress. VasThera’s VTA-04 program suggests the disease
modifying treatment option to pulmonary arterial hypertension patients which
required high unmet medical needs.
About
VASTHERA VasThera
is an innovative pharmaceutical company, located in Korea. VasThera develops
the first-in-class therapeutics targeting the vascular diseases, with a primary
focus in pulmonary arterial hypertension (PAH) and also oncology and
neurodegenerative disease. VasThera is the only company in the world possessing
novel small molecules capable of replacing the redox enzymes that regulate
receptor signaling.
About
BIO BIO
is the world’s largest trade association representing biotechnology companies,
academic institutions, state biotechnology centers, and related organizations
across the United States and in more than 30 other nations. BIO members are
involved in the research and development of innovative healthcare,
agricultural, industrial, and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest
gathering of the biotechnology industry, along with industry-leading investor
and partnering meetings held around the world. Good
Day BIO
is the only daily newsletter at the intersection of biotech, politics, and
policy. Subscribe here.
|
|
Prev | VasThera to Attend Bio Japan 2023 |
Next |